Skip to content
10-K

Annual Report

Revium Rx. RVRC

0001213900-26-037573

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 30, 2026 61.32M sh
Shares Diluted FY 2025 · Dec 31, 2025 60.73M sh
Shares Diluted FY 2025 · Dec 31, 2024 57.93M sh
Shares Diluted FY 2025 · Jul 23, 2024 143.45K sh
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.68M
Cash And Equivalents FY 2025 · Dec 31, 2024 $3.27M
Current Liabilities FY 2025 · Dec 31, 2025 $1.37M
Current Liabilities FY 2025 · Dec 31, 2024 $576K
Total Liabilities FY 2025 · Dec 31, 2025 $1.42M
Total Liabilities FY 2025 · Dec 31, 2024 $576K
Current Assets FY 2025 · Dec 31, 2025 $3.1M
Current Assets FY 2025 · Dec 31, 2024 $5.52M
Total Assets FY 2025 · Dec 31, 2025 $8.3M
Total Assets FY 2025 · Dec 31, 2024 $20.28M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.22
Eps Diluted FY 2025 · Dec 31, 2024 −$0.04
Eps Diluted FY 2025 · Jul 23, 2024 −$9.90
Eps Basic FY 2025 · Dec 31, 2025 −$0.22
Eps Basic FY 2025 · Dec 31, 2024 −$0.04
Eps Basic FY 2025 · Jul 23, 2024 −$9.90
Net Income FY 2025 · Dec 31, 2025 −$13.45M
Net Income FY 2025 · Dec 31, 2024 −$2.08M
Net Income FY 2025 · Jul 23, 2024 −$1.42M